BPA Call 36C24821A0045-36C24821K0036
- This contract award, valued at $7,920.00, was issued by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company, for the supply of blood glucose monitoring supplies for the month of August 2021. The contract was issued as a Blanket Purchase Agreement (BPA) call under the VA's GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test. This BPA enables the VA's Integrated Service Network 8 to efficiently procure critical medical diagnostic...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs to Abbott Laboratories Inc. for $12,150.00 to provide blood glucose monitoring supplies for the month of August 2021. The contract is under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test. No set-aside designation was used. The contract enables the VA to efficiently procure critical medical supplies for VA healthcare facilities through an existing IDV contract...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company based in North Chicago, Illinois. The contract is for the delivery of blood glucose monitoring supplies for the VA's Integrated Service Network 8 from June 2022 through September 2022, with a ceiling value of $8,113.50. The contract was awarded under the VA's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule....
- The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Abbott Laboratories Inc. for the provision of blood glucose monitoring supplies. The contract is valued at $38,016.00 and covers the period from February 2024 to August 2024, with a final completion date of January 15, 2025. The contract was awarded under the General Services Administration (GSA) Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Tests, and is a firm fixed-price vehicle....
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company, for the provision of blood glucose monitoring supplies. The contract, valued at $29,700.00, is a Blanket Purchase Agreement (BPA) call order under the VA's existing General Services Administration (GSA) Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test. The contract period of performance is from April 2022 to October 2022 and does not utilize...
- This is a Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a division of the global healthcare company Abbott Laboratories. The $7,285.50 contract is for the delivery of blood glucose monitoring supplies to support VA healthcare services from September 2022 through December 2022. The award was placed against Abbott's existing GSA Schedule contract for In-vitro Diagnostics, Reagents, and Test Kits, which allows VA...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc. to provide blood glucose monitoring supplies for the month of July 2024. The award amount is $23,100.00 and has no set-aside designation. This order is placed against Abbott Laboratories Inc.'s existing General Services Administration (GSA) Schedule contract for In-Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII), which allows the VA to...
- This is a firm fixed-price contract award from the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company, for the provision of blood glucose monitoring supplies for the period of October 2022 through January 2023. The contract, valued at $10,827.00, was awarded on October 6, 2022, and is a call against a Blanket Purchase Agreement (BPA) established under the VA's General Services Administration (GSA) Schedule 65-VII for In-Vitro Diagnostics,...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company and medical device manufacturer. The $8,100 contract is for the delivery of blood glucose monitoring supplies to support VA medical centers under the VA's Integrated Service Network 8. The contract is established under the VA's GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Tests, facilitating streamlined...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company that manufactures medical devices, diagnostic equipment, and pharmaceuticals. The contract, with a ceiling value of $8,280.00, is for the provision of blood glucose monitoring supplies for the VA from February 2023 to May 2023. The BPA was established under the VA's GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents,...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79721D0079-36C24821A0045Blanket Purchase Agreement
- 36C24821A0045-36C24821K0036BPA Call
This is a federal contract award from the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices, diagnostics, and pharmaceuticals. The $59,400.00 contract is for the delivery of blood glucose monitoring supplies for the month of August 2021. This is a Blanket Purchase Agreement (BPA) call under the VA's GSA Schedule 65-VII contract for In-Vitro Diagnostics, Reagents, and Tests. The contract has a firm fixed-price pricing type and was not set aside for small businesses. This contract supports the VA's Integrated Service Network 8, which oversees healthcare facilities in Florida, Puerto Rico, and the U.S. Virgin Islands. As a prime contractor, Abbott Laboratories Inc. has a significant history of providing critical medical products and services to federal agencies, particularly the VA and Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.4k | 8/2/21 |